{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:19:38Z","timestamp":1792783178549,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education","award":["RS-2025-25397793"],"award-info":[{"award-number":["RS-2025-25397793"]}],"id":[{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Hallym University Research Fund","id":[{"id":"https:\/\/ror.org\/03sbhge02","id-type":"ROR","asserted-by":"crossref"}]},{"name":"a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea","award":["HR21C0198"],"award-info":[{"award-number":["HR21C0198"]}],"id":[{"id":"https:\/\/ror.org\/00fdzyk40","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the National Research Foundation of Korea (NRF) grant funded by the Korean government","award":["RS-2022-NR070859"],"award-info":[{"award-number":["RS-2022-NR070859"]}],"id":[{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12932-2","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:22:33Z","timestamp":1792160553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Modeling Moyamoya disease using patient-derived induced pluripotent stem cells and organoids"],"prefix":"10.1007","volume":"53","author":[{"given":"Jong-Tae","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Hyuk","family":"Youn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Pyo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngmi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu-Won","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Jun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Pyeong","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"issue":"3","key":"12932_CR1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","volume":"20","author":"J Suzuki","year":"1969","unstructured":"Suzuki J, Takaku A (1969) Cerebrovascular moyamoya disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20(3):288\u2013299","journal-title":"Arch Neurol"},{"issue":"1","key":"12932_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s43556-025-00318-y","volume":"6","author":"X Cheng","year":"2025","unstructured":"Cheng X, Cao Y, Duan J, Zhou M, Ye S, Zhu Y (2025) Moyamoya disease: epidemiology, clinical features, pathogenesis, diagnosis and therapeutic interventions. Mol Biomed 6(1):76","journal-title":"Mol Biomed"},{"issue":"11","key":"12932_CR3","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/jhg.2010.103","volume":"55","author":"C Roder","year":"2010","unstructured":"Roder C, Nayak NR, Khan N, Tatagiba M, Inoue I, Krischek B (2010) Genetics of Moyamoya disease. J Hum Genet 55(11):711\u2013716","journal-title":"J Hum Genet"},{"issue":"1","key":"12932_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/jhg.2010.132","volume":"56","author":"F Kamada","year":"2011","unstructured":"Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, Kanno J, Niihori T, Ono M, Ishii N et al (2011) A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet 56(1):34\u201340","journal-title":"J Hum Genet"},{"issue":"7","key":"12932_CR5","doi-asserted-by":"publisher","first-page":"e22542","DOI":"10.1371\/journal.pone.0022542","volume":"6","author":"W Liu","year":"2011","unstructured":"Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, Hashikata H, Matsuura N, Yamazaki S, Toyoda A et al (2011) Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS ONE 6(7):e22542","journal-title":"PLoS ONE"},{"issue":"10","key":"12932_CR6","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s10038-023-01167-9","volume":"68","author":"JP Jeon","year":"2023","unstructured":"Jeon JP, Hong EP, Ha EJ, Kim BJ, Youn DH, Lee S, Lee HC, Kim KM, Lee SH, Cho WS et al (2023) Genome-wide association study identifies novel susceptibilities to adult moyamoya disease. J Hum Genet 68(10):713\u2013720","journal-title":"J Hum Genet"},{"issue":"1","key":"12932_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1161\/STROKEAHA.117.017430","volume":"49","author":"L Duan","year":"2018","unstructured":"Duan L, Wei L, Tian Y, Zhang Z, Hu P, Wei Q, Liu S, Zhang J, Wang Y, Li D et al (2018) Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study. Stroke 49(1):11\u201318","journal-title":"Stroke"},{"issue":"2","key":"12932_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3171\/jns.1991.75.2.0267","volume":"75","author":"M Hoshimaru","year":"1991","unstructured":"Hoshimaru M, Takahashi JA, Kikuchi H, Nagata I, Hatanaka M (1991) Possible roles of basic fibroblast growth factor in the pathogenesis of moyamoya disease: an immunohistochemical study. J Neurosurg 75(2):267\u2013270","journal-title":"J Neurosurg"},{"issue":"5302","key":"12932_CR9","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1126\/science.275.5302.964","volume":"275","author":"T Asahara","year":"1997","unstructured":"Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302):964\u2013967","journal-title":"Science"},{"issue":"3","key":"12932_CR10","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/jnr.22228","volume":"88","author":"JH Kim","year":"2010","unstructured":"Kim JH, Jung JH, Phi JH, Kang HS, Kim JE, Chae JH, Kim SJ, Kim YH, Kim YY, Cho BK et al (2010) Decreased level and defective function of circulating endothelial progenitor cells in children with moyamoya disease. J Neurosci Res 88(3):510\u2013518","journal-title":"J Neurosci Res"},{"issue":"2","key":"12932_CR11","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1161\/STROKEAHA.108.529420","volume":"40","author":"N Rafat","year":"2009","unstructured":"Rafat N, Beck G, Pe\u00f1a-Tapia PG, Schmiedek P, Vajkoczy P (2009) Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease. Stroke 40(2):432\u2013438","journal-title":"Stroke"},{"issue":"1","key":"12932_CR12","doi-asserted-by":"publisher","first-page":"e0169714","DOI":"10.1371\/journal.pone.0169714","volume":"12","author":"JH Phi","year":"2017","unstructured":"Phi JH, Suzuki N, Moon YJ, Park AK, Wang KC, Lee JY, Choi SA, Chong S, Shirane R, Kim SK (2017) Chemokine Ligand 5 (CCL5) Derived from Endothelial Colony-Forming Cells (ECFCs) Mediates Recruitment of Smooth Muscle Progenitor Cells (SPCs) toward Critical Vascular Locations in Moyamoya Disease. PLoS ONE 12(1):e0169714","journal-title":"PLoS ONE"},{"key":"12932_CR13","doi-asserted-by":"crossref","unstructured":"Tinelli F, Nava S, Arioli F, Bedini G, Scelzo E, Lisini D, Farag\u00f2 G, Gioppo A, Ciceri EF, Acerbi F et al (2020) Vascular Remodeling in Moyamoya Angiopathy: From Peripheral Blood Mononuclear Cells to Endothelial Cells. Int J Mol Sci 21(16):5763","DOI":"10.3390\/ijms21165763"},{"issue":"4","key":"12932_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s12264-023-01158-y","volume":"40","author":"H Li","year":"2024","unstructured":"Li H, Cao X, Gu X, Dong M, Huang L, Mao C, Xia S, Yang H, Bao X, Yang Y et al (2024) GM-CSF Promotes the Development of Dysfunctional Vascular Networks in Moyamoya Disease. Neurosci Bull 40(4):451\u2013465","journal-title":"Neurosci Bull"},{"key":"12932_CR15","doi-asserted-by":"publisher","first-page":"687088","DOI":"10.3389\/fneur.2021.687088","volume":"12","author":"Y Mineharu","year":"2021","unstructured":"Mineharu Y, Miyamoto S (2021) RNF213 and GUCY1A3 in Moyamoya Disease: Key Regulators of Metabolism, Inflammation, and Vascular Stability. Front Neurol 12:687088","journal-title":"Front Neurol"},{"issue":"10","key":"12932_CR16","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1177\/0271678X241245557","volume":"44","author":"HS Shin","year":"2024","unstructured":"Shin HS, Park GH, Choi ES, Park SY, Kim DS, Chang J, Hong JM (2024) RNF213 variant and autophagic impairment: A pivotal link to endothelial dysfunction in moyamoya disease. J Cereb Blood Flow Metab 44(10):1801\u20131815","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"12932_CR17","doi-asserted-by":"publisher","first-page":"13753","DOI":"10.1038\/s41598-023-40747-9","volume":"13","author":"DH Youn","year":"2023","unstructured":"Youn DH, Kim N, Lee A, Han SW, Kim JT, Hong EP, Jung H, Jeong MS, Cho SM, Jeon JP (2023) Autophagy and mitophagy-related extracellular mitochondrial dysfunction of cerebrospinal fluid cells in patients with hemorrhagic moyamoya disease. Sci Rep 13(1):13753","journal-title":"Sci Rep"},{"issue":"5","key":"12932_CR18","doi-asserted-by":"publisher","first-page":"e26748","DOI":"10.1016\/j.heliyon.2024.e26748","volume":"10","author":"J Liu","year":"2024","unstructured":"Liu J, Chen C, Qin X, Wang J, Zhang B, Jin F (2024) Plasma-derived exosomes contributes to endothelial-to-mesenchymal transition in Moyamoya disease. Heliyon 10(5):e26748","journal-title":"Heliyon"},{"issue":"3","key":"12932_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10048-020-00609-2","volume":"21","author":"J Key","year":"2020","unstructured":"Key J, Maletzko A, Kohli A, Gispert S, Torres-Odio S, Wittig I, Heidler J, B\u00e1rcena C, L\u00f3pez-Ot\u00edn C, Lei Y et al (2020) Loss of mitochondrial ClpP, Lonp1, and Tfam triggers transcriptional induction of Rnf213, a susceptibility factor for moyamoya disease. Neurogenetics 21(3):187\u2013203","journal-title":"Neurogenetics"},{"issue":"10","key":"12932_CR20","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1161\/01.STR.27.10.1750","volume":"27","author":"M Aoyagi","year":"1996","unstructured":"Aoyagi M, Fukai N, Yamamoto M, Nakagawa K, Matsushima Y, Yamamoto K (1996) Early development of intimal thickening in superficial temporal arteries in patients with moyamoya disease. Stroke 27(10):1750\u20131754","journal-title":"Stroke"},{"issue":"Suppl 2","key":"12932_CR21","doi-asserted-by":"publisher","first-page":"S213","DOI":"10.1016\/S0303-8467(97)00046-2","volume":"99","author":"M Aoyagi","year":"1997","unstructured":"Aoyagi M, Fukai N, Yamamoto M, Matsushima Y, Yamamoto K (1997) Development of intimal thickening in superficial temporal arteries in patients with moyamoya disease. Clin Neurol Neurosurg 99(Suppl 2):S213\u2013217","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"12932_CR22","doi-asserted-by":"publisher","first-page":"e36386","DOI":"10.1371\/journal.pone.0036386","volume":"7","author":"R Lin","year":"2012","unstructured":"Lin R, Xie Z, Zhang J, Xu H, Su H, Tan X, Tian D, Su M (2012) Clinical and immunopathological features of Moyamoya disease. PLoS ONE 7(4):e36386","journal-title":"PLoS ONE"},{"issue":"1","key":"12932_CR23","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s42003-025-09476-9","volume":"9","author":"S He","year":"2026","unstructured":"He S, Zhang J, Wang X, Qi Z, Zhou Z, Wang Y, Xu S, Li D, Ye X, Liu Z et al (2026) Organoid Modeling and Single-Cell Profiling Reveal Smooth Muscle Cell Migration in Moyamoya Disease. Commun Biol 9(1):198","journal-title":"Commun Biol"},{"issue":"12","key":"12932_CR24","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1161\/01.STR.24.12.1960","volume":"24","author":"J Masuda","year":"1993","unstructured":"Masuda J, Ogata J, Yutani C (1993) Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in moyamoya disease. Stroke 24(12):1960\u20131967","journal-title":"Stroke"},{"issue":"1","key":"12932_CR25","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1038\/s41598-025-30964-9","volume":"16","author":"C Asselman","year":"2025","unstructured":"Asselman C, Meersschaut J, Willems P, Mortier J, Vernaillen F, Dhondt E, Sieben A, Libbrecht S, Fernandez E, Gevaert K et al (2025) Increased plasma fibronectin mirrors intimal phenotypic switching of vascular smooth muscle cells in moyamoya arteriopathy. Sci Rep 16(1):1590","journal-title":"Sci Rep"},{"issue":"1","key":"12932_CR26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12964-022-00993-2","volume":"20","author":"G Cao","year":"2022","unstructured":"Cao G, Xuan X, Hu J, Zhang R, Jin H, Dong H (2022) How vascular smooth muscle cell phenotype switching contributes to vascular disease. Cell Commun Signal 20(1):180","journal-title":"Cell Commun Signal"},{"key":"12932_CR27","doi-asserted-by":"crossref","unstructured":"Fang YC, Wei LF, Hu CJ, Tu YK (2021) Pathological Circulating Factors in Moyamoya Disease. Int J Mol Sci 22(4):1696","DOI":"10.3390\/ijms22041696"},{"key":"12932_CR28","doi-asserted-by":"publisher","first-page":"1081881","DOI":"10.3389\/fphys.2022.1081881","volume":"13","author":"S D\u00e9glise","year":"2022","unstructured":"D\u00e9glise S, Bechelli C, Allagnat F (2022) Vascular smooth muscle cells in intimal hyperplasia, an update. Front Physiol 13:1081881","journal-title":"Front Physiol"},{"issue":"6","key":"12932_CR29","doi-asserted-by":"publisher","first-page":"C1375","DOI":"10.1152\/ajpcell.00670.2008","volume":"300","author":"Y Zhao","year":"2011","unstructured":"Zhao Y, Biswas SK, McNulty PH, Kozak M, Jun JY, Segar L (2011) PDGF-induced vascular smooth muscle cell proliferation is associated with dysregulation of insulin receptor substrates. Am J Physiol Cell Physiol 300(6):C1375\u20131385","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"12932_CR30","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.surneu.2008.10.009","volume":"72","author":"M Fujimura","year":"2009","unstructured":"Fujimura M, Watanabe M, Narisawa A, Shimizu H, Tominaga T (2009) Increased expression of serum Matrix Metalloproteinase-9 in patients with moyamoya disease. Surg Neurol 72(5):476\u2013480 discussion 480","journal-title":"Surg Neurol"},{"issue":"9","key":"12932_CR31","doi-asserted-by":"publisher","first-page":"e0221811","DOI":"10.1371\/journal.pone.0221811","volume":"14","author":"X Peng","year":"2019","unstructured":"Peng X, Zhang Z, Ye D, Xing P, Zou Z, Lei H, Duan L (2019) Gene dysregulation in peripheral blood of moyamoya disease and comparison with other vascular disorders. PLoS ONE 14(9):e0221811","journal-title":"PLoS ONE"},{"issue":"6","key":"12932_CR32","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/jnnp.2009.191817","volume":"81","author":"HS Kang","year":"2010","unstructured":"Kang HS, Kim JH, Phi JH, Kim YY, Kim JE, Wang KC, Cho BK, Kim SK (2010) Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. J Neurol Neurosurg Psychiatry 81(6):673\u2013678","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"12932_CR33","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1177\/0271678X16658301","volume":"37","author":"KG Blecharz","year":"2017","unstructured":"Blecharz KG, Frey D, Schenkel T, Prinz V, Bedini G, Krug SM, Czabanka M, Wagner J, Fromm M, Bersano A et al (2017) Autocrine release of angiopoietin-2 mediates cerebrovascular disintegration in Moyamoya disease. J Cereb Blood Flow Metab 37(4):1527\u20131539","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12","key":"12932_CR34","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1161\/STROKEAHA.123.044476","volume":"54","author":"S He","year":"2023","unstructured":"He S, Zhang J, Liu Z, Wang Y, Hao X, Wang X, Zhou Z, Ye X, Zhao Y, Zhao Y et al (2023) Upregulated Cytoskeletal Proteins Promote Pathological Angiogenesis in Moyamoya Disease. Stroke 54(12):3153\u20133164","journal-title":"Stroke"},{"issue":"2","key":"12932_CR35","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3171\/2024.11.JNS241804","volume":"143","author":"S He","year":"2025","unstructured":"He S, Zhang J, Zhou Z, Wang Y, Wang X, Niu H, Zhao Y, Ye X (2025) Serum amyloid A2-induced phenotypic switching of vascular smooth muscle cells in moyamoya disease. J Neurosurg 143(2):530\u2013542","journal-title":"J Neurosurg"},{"issue":"12","key":"12932_CR36","doi-asserted-by":"publisher","first-page":"e1492","DOI":"10.1002\/ctm2.1492","volume":"13","author":"S He","year":"2023","unstructured":"He S, Wang Y, Liu Z, Zhang J, Hao X, Wang X, Zhou Z, Wang R, Zhao Y (2023) Metabolomic signatures associated with pathological angiogenesis in moyamoya disease. Clin Transl Med 13(12):e1492","journal-title":"Clin Transl Med"},{"issue":"11","key":"12932_CR37","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.1093\/brain\/awad225","volume":"146","author":"F Ye","year":"2023","unstructured":"Ye F, Niu X, Liang F, Dai Y, Liang J, Li J, Wu X, Zheng H, Qi T, Sheng W (2023) RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathway. Brain 146(11):4674\u20134689","journal-title":"Brain"},{"issue":"10","key":"12932_CR38","doi-asserted-by":"publisher","first-page":"12938","DOI":"10.1007\/s12035-025-05103-0","volume":"62","author":"J Shen","year":"2025","unstructured":"Shen J, Wang Y, Qin Y, Chen G, Xu J, Li Y, Hou Y, Liu Y, Liu W (2025) RNF213 Knockdown and Inflammation Promote Angiogenesis and Phenotype Switching by JAK2\/STAT3 Pathway in Moyamoya Disease. Mol Neurobiol 62(10):12938\u201312950","journal-title":"Mol Neurobiol"},{"key":"12932_CR39","doi-asserted-by":"crossref","unstructured":"Kobayashi H, Matsuda Y, Hitomi T, Okuda H, Shioi H, Matsuda T, Imai H, Sone M, Taura D, Harada KH et al (2015) Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo. J Am Heart Assoc 4(7)","DOI":"10.1161\/JAHA.115.002146"},{"issue":"3","key":"12932_CR40","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.scr.2016.11.006","volume":"17","author":"M Cardano","year":"2016","unstructured":"Cardano M, Marsoner F, Marcatili M, Karnavas T, Zasso J, Lanterna LA, Conti L (2016) Establishment of induced pluripotent stem cell (iPSC) line from 55-year old male patient with hemorrhagic Moyamoya disease. Stem Cell Res 17(3):623\u2013626","journal-title":"Stem Cell Res"},{"key":"12932_CR41","doi-asserted-by":"publisher","first-page":"102575","DOI":"10.1016\/j.scr.2021.102575","volume":"57","author":"Z Mao","year":"2021","unstructured":"Mao Z, Li Y, Huang L, Chen Y, Luo H, Zhang S, Chen H (2021) Generation of an induced pluripotent stem cell line HUSTTJi001-A from a Moyamoya disease patient with RNF213 gene mutation. Stem Cell Res 57:102575","journal-title":"Stem Cell Res"},{"issue":"12","key":"12932_CR42","doi-asserted-by":"publisher","first-page":"105305","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105305","volume":"29","author":"K Tokairin","year":"2020","unstructured":"Tokairin K, Hamauchi S, Ito M, Kazumata K, Sugiyama T, Nakayama N, Kawabori M, Osanai T, Houkin K (2020) Vascular Smooth Muscle Cell Derived from IPS Cell of Moyamoya Disease - Comparative Characterization with Endothelial Cell Transcriptome. J Stroke Cerebrovasc Dis 29(12):105305","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"12932_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bbrc.2013.07.004","volume":"438","author":"T Hitomi","year":"2013","unstructured":"Hitomi T, Habu T, Kobayashi H, Okuda H, Harada KH, Osafune K, Taura D, Sone M, Asaka I, Ameku T et al (2013) Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G\u2009>\u2009A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients. Biochem Biophys Res Commun 438(1):13\u201319","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"12932_CR44","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2174\/1574888X17666220607121027","volume":"18","author":"Y Xue","year":"2023","unstructured":"Xue Y, Zhang Q, Wang LJ, Tu WJ, Zhao J (2023) Application of Induced Pluripotent Stem Cells in Moyamoya Disease: Progress and Promises. Curr Stem Cell Res Ther 18(6):733\u2013739","journal-title":"Curr Stem Cell Res Ther"},{"issue":"9","key":"12932_CR45","doi-asserted-by":"publisher","first-page":"e0163561","DOI":"10.1371\/journal.pone.0163561","volume":"11","author":"S Hamauchi","year":"2016","unstructured":"Hamauchi S, Shichinohe H, Uchino H, Yamaguchi S, Nakayama N, Kazumata K, Osanai T, Abumiya T, Houkin K, Era T (2016) Cellular Functions and Gene and Protein Expression Profiles in Endothelial Cells Derived from Moyamoya Disease-Specific iPS Cells. PLoS ONE 11(9):e0163561","journal-title":"PLoS ONE"},{"issue":"4","key":"12932_CR46","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.bbrc.2013.08.067","volume":"439","author":"T Hitomi","year":"2013","unstructured":"Hitomi T, Habu T, Kobayashi H, Okuda H, Harada KH, Osafune K, Taura D, Sone M, Asaka I, Ameku T et al (2013) The moyamoya disease susceptibility variant RNF213 R4810K (rs112735431) induces genomic instability by mitotic abnormality. Biochem Biophys Res Commun 439(4):419\u2013426","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"12932_CR47","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S1474-4422(22)00165-X","volume":"21","author":"M Ihara","year":"2022","unstructured":"Ihara M, Yamamoto Y, Hattori Y, Liu W, Kobayashi H, Ishiyama H, Yoshimoto T, Miyawaki S, Clausen T, Bang OY et al (2022) Moyamoya disease: diagnosis and interventions. Lancet Neurol 21(8):747\u2013758","journal-title":"Lancet Neurol"},{"issue":"9","key":"12932_CR48","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1007\/s00415-019-09406-w","volume":"266","author":"M Kraemer","year":"2019","unstructured":"Kraemer M, Keyvani K, Berlit P, Diesner F, Marquardt M (2019) Histopathology of Moyamoya angiopathy in a European patient. J Neurol 266(9):2258\u20132262","journal-title":"J Neurol"},{"issue":"11","key":"12932_CR49","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1161\/STROKEAHA.124.046859","volume":"55","author":"M Brokbals","year":"2024","unstructured":"Brokbals M, Pilgram-Pastor S, Focke JK, Strunk D, Veltkamp R, Kraemer M (2024) Hemorrhagic Moyamoya Angiopathy in European Patients. Stroke 55(11):2661\u20132668","journal-title":"Stroke"},{"issue":"1","key":"12932_CR50","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41392-024-01809-0","volume":"9","author":"J Cerneckis","year":"2024","unstructured":"Cerneckis J, Cai H, Shi Y (2024) Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications. Signal Transduct Target Ther 9(1):112","journal-title":"Signal Transduct Target Ther"},{"key":"12932_CR51","doi-asserted-by":"crossref","unstructured":"Fontanelli L, Castronovo A, Ferri C, Vozzi F, Recchia FA, Borghini A (2026) iPSC-Derived Endothelial Cells as Experimental Models for Predictive and Personalized Strategies in Cardiovascular and Cerebrovascular Disease. Int J Mol Sci 27(2):780","DOI":"10.3390\/ijms27020780"},{"issue":"4","key":"12932_CR52","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1161\/STROKEAHA.120.032691","volume":"53","author":"V Roy","year":"2022","unstructured":"Roy V, Ross JP, P\u00e9pin R, Cortez Ghio S, Brodeur A, Touzel Desch\u00eanes L, Le-Bel G, Phillips DE, Milot G, Dion PA et al (2022) Moyamoya Disease Susceptibility Gene RNF213 Regulates Endothelial Barrier Function. Stroke 53(4):1263\u20131275","journal-title":"Stroke"},{"issue":"3","key":"12932_CR53","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1177\/0271678X251409022","volume":"46","author":"A Halkoluoto","year":"2026","unstructured":"Halkoluoto A, Dhungana H, Keuters MH (2026) Advances in three-dimensional modeling of ischemic injury. J Cereb Blood Flow Metab 46(3):639\u2013651","journal-title":"J Cereb Blood Flow Metab"},{"key":"12932_CR54","doi-asserted-by":"crossref","unstructured":"Padmanaban AM, Ganesan K, Ramkumar KM (2024) A Co-Culture System for Studying Cellular Interactions in Vascular Disease. Bioeng (Basel) 11(11):1090","DOI":"10.3390\/bioengineering11111090"},{"issue":"7740","key":"12932_CR55","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41586-018-0858-8","volume":"565","author":"RA Wimmer","year":"2019","unstructured":"Wimmer RA, Leopoldi A, Aichinger M, Wick N, Hantusch B, Novatchkova M, Taubenschmid J, H\u00e4mmerle M, Esk C, Bagley JA et al (2019) Human blood vessel organoids as a model of diabetic vasculopathy. Nature 565(7740):505\u2013510","journal-title":"Nature"},{"key":"12932_CR56","doi-asserted-by":"publisher","first-page":"104979","DOI":"10.1016\/j.mvr.2026.104979","volume":"167","author":"M Wu","year":"2026","unstructured":"Wu M, Li S, Liu W, Guo Z, Guo Z, Zhang D (2026) RNF213 deficiency in human iPSC-derived vascular organoids captures key feature of moyamoya disease vasculopathy. Microvasc Res 167:104979","journal-title":"Microvasc Res"},{"key":"12932_CR57","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.brainres.2014.01.011","volume":"1552","author":"S Sonobe","year":"2014","unstructured":"Sonobe S, Fujimura M, Niizuma K, Nishijima Y, Ito A, Shimizu H, Kikuchi A, Arai-Ichinoi N, Kure S, Tominaga T (2014) Temporal profile of the vascular anatomy evaluated by 9.4-T magnetic resonance angiography and histopathological analysis in mice lacking RNF213: a susceptibility gene for moyamoya disease. Brain Res 1552:64\u201371","journal-title":"Brain Res"},{"key":"12932_CR58","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.brainres.2015.10.055","volume":"1630","author":"M Sato-Maeda","year":"2016","unstructured":"Sato-Maeda M, Fujimura M, Kanoke A, Morita-Fujimura Y, Niizuma K, Tominaga T (2016) Transient middle cerebral artery occlusion in mice induces neuronal expression of RNF213, a susceptibility gene for moyamoya disease. Brain Res 1630:50\u201355","journal-title":"Brain Res"},{"issue":"9","key":"12932_CR59","doi-asserted-by":"publisher","first-page":"6642","DOI":"10.1007\/s12035-024-03998-9","volume":"61","author":"M Rizzuti","year":"2024","unstructured":"Rizzuti M, Melzi V, Brambilla L, Quetti L, Sali L, Ottoboni L, Meneri M, Ratti A, Verde F, Ticozzi N et al (2024) Shaping the Neurovascular Unit Exploiting Human Brain Organoids. Mol Neurobiol 61(9):6642\u20136657","journal-title":"Mol Neurobiol"},{"issue":"3","key":"12932_CR60","doi-asserted-by":"publisher","first-page":"e70161","DOI":"10.1111\/cpr.70161","volume":"59","author":"Y Song","year":"2026","unstructured":"Song Y, Jo H, Jeong S, Kim I, Lee SS (2026) Vascularised Brain Organoids: Engineering Strategies and Neurobiological Applications. Cell Prolif 59(3):e70161","journal-title":"Cell Prolif"},{"issue":"6","key":"12932_CR61","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.tibtech.2024.11.021","volume":"43","author":"L Kistemaker","year":"2025","unstructured":"Kistemaker L, van Bodegraven EJ, de Vries HE, Hol EM (2025) Vascularized human brain organoids: current possibilities and prospects. Trends Biotechnol 43(6):1275\u20131285","journal-title":"Trends Biotechnol"},{"issue":"8","key":"12932_CR62","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.tibtech.2020.11.014","volume":"39","author":"N Picollet-D\u2019hahan","year":"2021","unstructured":"Picollet-D\u2019hahan N, Zuchowska A, Lemeunier I, Le Gac S (2021) Multiorgan-on-a-Chip: A Systemic Approach To Model and Decipher Inter-Organ Communication. Trends Biotechnol 39(8):788\u2013810","journal-title":"Trends Biotechnol"},{"issue":"1","key":"12932_CR63","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41380-022-01892-1","volume":"28","author":"W Zhang","year":"2023","unstructured":"Zhang W, Jiang J, Xu Z, Yan H, Tang B, Liu C, Chen C, Meng Q (2023) Microglia-containing human brain organoids for the study of brain development and pathology. Mol Psychiatry 28(1):96\u2013107","journal-title":"Mol Psychiatry"},{"key":"12932_CR64","doi-asserted-by":"crossref","unstructured":"Tran M, Jeong HW, An M, Been C, Jamsranjav A, Kwak SM, Lee LP, Cho H (2026) A 3D gut-brain-vascular platform for bidirectional crosstalk in gut-neuropathogenesis. Nat Commun 17(1):2504","DOI":"10.1038\/s41467-026-69318-y"},{"issue":"1","key":"12932_CR65","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41392-022-01024-9","volume":"7","author":"XY Tang","year":"2022","unstructured":"Tang XY, Wu S, Wang D, Chu C, Hong Y, Tao M, Hu H, Xu M, Guo X, Liu Y (2022) Human organoids in basic research and clinical applications. Signal Transduct Target Ther 7(1):168","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"12932_CR66","doi-asserted-by":"publisher","first-page":"101676","DOI":"10.1016\/j.jpha.2026.101676","volume":"16","author":"G Zhang","year":"2026","unstructured":"Zhang G, Zhang R, Shu Z, Zhao J, Yin L, Shi M, Han Y (2026) Recent advances and expanding applications of organoid models in unveiling drug ADME profiles. J Pharm Anal 16(6):101676","journal-title":"J Pharm Anal"},{"issue":"1","key":"12932_CR67","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41392-022-01194-6","volume":"7","author":"Q Wang","year":"2022","unstructured":"Wang Q, Guo F, Jin Y, Ma Y (2022) Applications of human organoids in the personalized treatment for digestive diseases. Signal Transduct Target Ther 7(1):336","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"12932_CR68","first-page":"100620","volume":"5","author":"X Han","year":"2024","unstructured":"Han X, Cai C, Deng W, Shi Y, Li L, Wang C, Zhang J, Rong M, Liu J, Fang B et al (2024) Landscape of human organoids: Ideal model in clinics and research. Innov (Camb) 5(3):100620","journal-title":"Innov (Camb)"},{"key":"12932_CR69","doi-asserted-by":"crossref","unstructured":"Roy V, Brodeur A, Touzel Desch\u00eanes L, Dupr\u00e9 N, Gros-Louis F (2022) RNF213 Loss-of-Function Promotes Angiogenesis of Cerebral Microvascular Endothelial Cells in a Cellular State Dependent Manner. Cells 12(1):78","DOI":"10.3390\/cells12010078"},{"issue":"1","key":"12932_CR70","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41392-023-01309-7","volume":"8","author":"T Li","year":"2023","unstructured":"Li T, Yang Y, Qi H, Cui W, Zhang L, Fu X, He X, Liu M, Li PF, Yu T (2023) CRISPR\/Cas9 therapeutics: progress and prospects. Signal Transduct Target Ther 8(1):36","journal-title":"Signal Transduct Target Ther"},{"key":"12932_CR71","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.omtm.2020.05.028","volume":"18","author":"JA Depla","year":"2020","unstructured":"Depla JA, Sogorb-Gonzalez M, Mulder LA, Heine VM, Konstantinova P, van Deventer SJ, Wolthers KC, Pajkrt D, Sridhar A, Evers MM (2020) Cerebral Organoids: A Human Model for AAV Capsid Selection and Therapeutic Transgene Efficacy in the Brain. Mol Ther Methods Clin Dev 18:167\u2013175","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"15","key":"12932_CR72","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1016\/j.cell.2022.03.045","volume":"185","author":"A Raguram","year":"2022","unstructured":"Raguram A, Banskota S, Liu DR (2022) Therapeutic in vivo delivery of gene editing agents. Cell 185(15):2806\u20132827","journal-title":"Cell"},{"issue":"2","key":"12932_CR73","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/jnt6020010","volume":"6","author":"P Guzm\u00e1n-Sastoque","year":"2025","unstructured":"Guzm\u00e1n-Sastoque P, Rodr\u00edguez CF, Monsalve MC, Castellanos S, Manrique-Moreno A, Reyes LH, Cruz JC (2025) Nanotheranostics Revolutionizing Gene Therapy: Emerging Applications in Gene Delivery Enhancement. J Nanotheranostics 6(2):10","journal-title":"J Nanotheranostics"},{"issue":"1","key":"12932_CR74","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12920-018-0385-3","volume":"11","author":"H Uchino","year":"2018","unstructured":"Uchino H, Ito M, Kazumata K, Hama Y, Hamauchi S, Terasaka S, Sasaki H, Houkin K (2018) Circulating miRNome profiling in Moyamoya disease-discordant monozygotic twins and endothelial microRNA expression analysis using iPS cell line. BMC Med Genomics 11(1):72","journal-title":"BMC Med Genomics"},{"issue":"1","key":"12932_CR75","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1038\/s41598-021-81282-9","volume":"11","author":"M Matsuo","year":"2021","unstructured":"Matsuo M, Nadanaka S, Soga M, Sugiyama T, Serigano S, Shimano K, Ichinose F, Nakamura T, Maeda T, Houkin K et al (2021) Vulnerability to shear stress caused by altered peri-endothelial matrix is a key feature of Moyamoya disease. Sci Rep 11(1):1552","journal-title":"Sci Rep"},{"issue":"3","key":"12932_CR76","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.scr.2016.11.007","volume":"17","author":"M Cardano","year":"2016","unstructured":"Cardano M, Marsoner F, Zasso J, Marcatili M, Karnavas T, Lanterna LA, Conti L (2016) Establishment of induced pluripotent stem cell (iPSC) line from an 8-year old female patient with ischemic Moyamoya disease. Stem Cell Res 17(3):619\u2013622","journal-title":"Stem Cell Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12932-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12932-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12932-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:03:30Z","timestamp":1792199010000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12932-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12932"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12932-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"3 September 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1750"}}